跳至主要内容
临床试验/NCT03822169
NCT03822169已完成不适用

Choline Uptake Study

Wageningen University and Research2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2019年2月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
2
主要终点
change in plasma betaine concentration

研究概览

简要总结

The study is a randomised, cross-over, double blind, controlled trial in which study participants will visit the research facility on two occasions under fasting conditions with a washout period of one week. During each visit, study subjects will receive a test shake with phospholipid-bound choline or a control shake with choline added as a salt and DHA added separately. The two shakes will be given in randomised order and blood will be collected via a catheter before and up-to 6 hours after choline consumption. All study participants will receive a standardised evening meal prior to each study day and asked not to drink alcohol or perform heavy exercise the day before each study day. Study subjects are also asked to avoid choline rich products the day before each test day. Study participants are offered a meal after the test day.

详细描述

Choline is water-soluble vitamin-like essential nutrient. It is made in small amounts by the liver, but humans need to receive choline through the diet or by supplementation for proper health. Pregnancy and lactation are times when demand for choline is especially high. Infant formula not made from cow's milk is therefore supplemented with choline. Choline is therefore widely used. It is normally added to food products as a salt. However, if choline is present in a natural form, bound to phospholipids, it may be more efficiently absorbed. Docosahexaenoic acids (DHA) are also bound to these phospholipids.

The primary objective is determine choline uptake and bioavailability after consumption of a test shake with phospholipid-bound choline (and DHA), and to compare this to a control shake with choline added as a salt (and DHA added as an oil). Secondary objective is to compare the uptake and bioavailability of DHA after the two shakes.

The study is a cross-over, double blind, controlled trial in which study participants will visit the research facility on two occasions under fasting conditions. Subjects will receive two different choline products in randomized order with a washout period of one week. Blood will be collected via a catheter before and up-to 6 hours after choline consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Apparently healthy men and women
  • Age between 30 and 70 years
  • Body mass index (BMI) between 18.5 and 24.9 kg/m2
  • Having veins suitable for blood sampling via a catheter (judged by study nurse/ medical doctor)

排除标准

  • Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease)
  • History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints
  • History of liver dysfunction (cirrhosis, hepatitis) or liver surgery
  • Kidney dysfunction (self-reported)
  • Use of medication that may influence the study results,
  • such as laxatives, stomach protectors and drugs that can affect intestinal motility.
  • Use of choline or fish oil supplements
  • Reported slimming, medically prescribed or vegan diet
  • Current smokers
  • Alcohol intake ≥4 glasses of alcoholic beverages per day
  • Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported)
  • Abuse of illicit drugs
  • Food allergies for products that we use in the study
  • Participation in another clinical trial at the same time
  • Being an employee of the department Consumer Science & Health group of Wageningen Food & Biobased Research and/or Human Nutrition and Health

研究组 & 干预措施

Choline added as a phospholipid

Experimental

A shake with phospholipid-bound choline (and bound DHA),

干预措施: Choline added as a phospholipid (Dietary Supplement)

Choline added as a salt

Active Comparator

control shake with choline added as a salt and added DHA.

干预措施: Choline added as a salt (Dietary Supplement)

结局指标

主要结局

change in plasma betaine concentration

时间窗: blood samples will be taken before and up to 6 hours after shake consumption

postprandial test, determine betaine in blood samples collected before and after a shake

change in plasma choline concentration

时间窗: blood samples will be taken before and up to 6 hours after shake consumption

postprandial test, determine choline in blood samples collected before and after a shake

change in plasma dimethylglycine concentration

时间窗: blood samples will be taken before and up to 6 hours after shake consumption

postprandial test, determine dimethylglycine in blood samples collected before and after a shake

次要结局

  • Change in plasma DHA concentration(blood samples will be taken before and up to 6 hours after shake consumption)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diederik Esser

project leader clinical trials

Wageningen University and Research

研究点 (2)

Loading locations...

相似试验